US To Buy 10M Courses Of Pfizer COVID Pill In $5B Deal

Reuters reports:

Pfizer Inc has signed a $5.29 billion deal with the U.S. government to deliver 10 million courses of its COVID-19 oral antiviral drug starting this year, the drugmaker said on Thursday.

Pfizer on Tuesday filed for U.S. authorization of the drug, Paxlovid, and said it expects to manufacture 180,000 treatment courses by the end of next month and at least 50 million courses by the end of 2022.

“This promising treatment could help accelerate our path out of this pandemic by offering another life-saving tool for people who get sick with COVID-19,” said Xavier Becerra, secretary of the United States Department of Health and Human Services.

Read the full article.

U.S. govt to buy 10 mln courses of Pfizer’s COVID-19 pill for $5.29 bln #Pfizer #COVID-19https://t.co/I4MyIKq2rT

— Julia Sanders (@dogeattache) November 18, 2021